Publications
5891 Results
- Journal / Conference
- Journal of Clinical Oncology Dec 10;32(35):3948-3958
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9347 (INT-0142) (E3193)
Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group
- Journal / Conference
- Journal of Thoracic Oncology Oct;9(10):1443-1448
- Year
- 2014
- Research Committee(s)
- Lung
- PMID
- PMID25521397
- PMC
- PMC4165474
- Study Number(s)
- S1400
Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer
- Journal / Conference
- Journal of Clinical Oncology Dec 10;32(35):3959-3966
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID25348000
- PMC
- PMC4251959
Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance)
- Journal / Conference
- Journal of Clinical Oncology Sep 20;32(27):3059-3068
- Year
- 2014
- Research Committee(s)
- Lymphoma
- PMID
- PMID25113753
- PMC
- PMC4979083
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification Consortium [includes representation by SWOG]
- Journal / Conference
- Journal of Translational Medicine Oct 28;12(1):277
- Year
- 2014
- Research Committee(s)
- Melanoma
- PMID
- PMID25348889
- PMC
- PMC4232645
- Study Number(s)
- S0008, S1404
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
- Journal / Conference
- Asian Journal of Andrology May-Jun;16(3):414
- Year
- 2014
- Research Committee(s)
- Cancer Control
- PMID
- PMID24914438
- PMC
- PMC4023368
- Study Number(s)
- SWOG-9217
Re: Long-term survival of participants in the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of Clinical Oncology 32:5s(suppl; abstr 632); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), general poster session;
- Year
- 2014
- Research Committee(s)
- Breast
Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance)
- Journal / Conference
- Leukemia & Lymphoma 55(7):1523-1532
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24160850
- PMC
- PMC4273565
- Study Number(s)
- C9710
Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype
- Journal / Conference
- Urologic Oncology 32(8):1108-15;
- Year
- 2014
- Research Committee(s)
- Genitourinary
- PMID
- PMID25443274
- PMC
- PMC4262150
- Study Number(s)
- S1314
Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum
- Journal / Conference
- American Journal of Geriatric Psychiatry Oct;22(10):997-1006
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID24791650
- PMC
- PMC4163500
- Study Number(s)
- S0000